Pharmaceutical R&D project management under risk

Yin Huang, Xiamiao Li, Dapeng Liu


Market pressure and tough socio-political regulations are among the current factors that are changing the way in which the pharmaceutical business is operated. Pharmaceutical companies are faced with the question of the best use of limited resources available to obtain the highest possible profit from a potential product portfolio. Pharmaceutical products differ somewhat from other products. In this sense, pharmaceutical research and development (R&D) project management under risk is crucial for quick responses to changing market trends. For this reason, a great deal of recent research has focused on R&D projects. This article reviews the current literature on R&D project management under risk for medical and pharmaceutical products. The review discusses some interesting open research questions in this field, and points out new directions for future research.

Full Text:



Acevedo, J. and Pistikopoulos, E.N. (1998) Stochastic optimization based algorithms for process synthesis under uncertainty, Computers and Chemical Engineering, 22(4-5): 647–671.

Applequist, G.E., Pekny, J.F. and Reklaitis. G.V. (2000) Risk and uncertainty in managing chemical manufacturing supply chains, Computers and Chemical Engineering, 24(9–10): 2211–2222.

Blau, G., Mehta, B., Bose, S., Pekny, J., Sinclair, G., Keunker, K. and Bunch, P. (2000). Risk management in the development of new products in highly regulated industries. Computers and Chemical Engineering, 24, 1005–1011.

Bhagwat, Y. and Griggs, F. T. (1995) Analysis of riskiness of pharmaceutical industry firms. Journal of Research in Pharmaceutical Economics, 6, 65–76.

Bok, J., Lee, H. and Park, S. (1998) Robust investment model for long range capacity expansion of chemical processing networks under uncertain demand forecast scenarios. Computers and Chemical Engineering, 22, 1037–1050.

Clay, R. L. and Grossmann, I. E. (1997) A disaggregation algorithm for the optimization of stochastic planning models. Computers and Chemical Engineering, 21, 751–774.

Escudero, L.F., Galindo, E., Garca, G., Gomez, E. and Sabau, V. (1999a) Schumman, a modeling framework for supply chain management under uncertainty. European Journal of Operational Research, 119: 14–34.

Folland S., Goodman A.C. and Stano, M. The Economics of Health and Health Care. (4th Editon). USA: Pearson Prentice Hall. 2004: 642–643.

Gatica, G., Shah, N. and Papageorgiou, L.G. (2001) Capacity planning under clinical trials uncertainty for the pharmaceutical industry. Proceedings ESCAPE-11, Kolding, Denmark, 865–870.

Gatica, G., Papageorgiou, L. G. and Shah, N. (2002b) An aggregation approach for capacity planning under uncertainty for the pharmaceutical industry. FOCAPO-2003.

Gatica, G., Papageorgiou, L.G. and Shah, N. (2003) Capacity planning under uncertainty for the pharmaceutical industry. Chemical Engineering Research and Design. 81(6): 665-678.

Grabowski H. and Vernon J. (1998) The Determinants of Pharmaceutical Research and Development Expenditures. (1998) World Conference of the International Joseph A. Schumpeter Society. Vienna, Austria.

Gupta, A. and Maranas, C. D. (2000) A Two-Stage Modeling and Solution Framework for Multisite Midterm Planning Under Demand Uncertainty, Industrial and Engineering Chemistry Research,

, 3799.

Huchzermeier, A. and Loch, C. H. (2001) Project Management Under Risk: Using the Real Options Approach to Evaluate Flexibility in R&D. Management Science, 47(1): 85-101.

Ierapetritou, M.G., Pistikopoulos, E.N. and Floudas, C.A. (1994) Operational planning under uncertainty. Computers and Chemical Engineering, S18: S553–S557.

Kall, P. and Wallace, S. W. (1994) Stochastic Programming. New York: Wiley.

Kleczyk, E. (2008) Risk management in the development of new products in the pharmaceutical industry. African Journal of Business Management. 2(10): 186-194.

Lazaros, G. et al. (2001) Strategic Supply Chain Optimization for the Pharmaceutical Industries. Industrial and Engineering Chemistry Research, 40(1): 275-286.

Lintner, J. (1969). The valuation of risk assets and the selection of risky investments in stock portfolios and capital budgets. Review of Economic Statistics, 51 (2), 222–224.

Loch, C.H. and Bode-Greuel, K. Evaluating Growth Options as Sources of Value for Pharmaceutical Research Projects. R&D Management. 31, 231.

Maraelis, C.T. and Grossmann, I.E. (2001) Simultaneous planning for new product development and batch manufacturing facilities. Industrial and Engineering Chemistry Research, 40(26): 6147-6164.

Mulvey, J. M., Rosenbaum, D. P. and Shetty, B. (1997) Strategic financial risk management and operations research. European Journal of Operational Research, 97, 1–16.

Papageorgiou, L.G., Rotstein, G.E. and Shah, N. (2001) Strategic supply chain optimization for the pharmaceutical industries, Industrial and Engineering Chemistry Research, 40(1): 275–286.

Petkov, S. B. and Maranas, C. D. (1997) Multiperiod planning and scheduling of multiproduct batch plants under demand uncertainty. Industrial and Engineering Chemistry Research, 36, 4864–4881.

Rotstein, G. E., Papageorgiou, L. G., Shah, N., Murphy, D. C. and Mustafa, R. (1999) A product portfolio approach in the pharmaceutical industry. Computers and Chemical Engineering, 23, 883–886.

Rogers M.J., Gupta, A. and Maranas, C.D. (2002) Real Options Based Analysis of Optimal Pharmaceutical Research and Development Portfolios. Industrial and Engineering Chemistry Research, 41(25): 6607-6620.

Rogers M.J., Gupta, A. and Maranas, C.D. (2003) Risk Management in Real Options Based Pharmaceutical Portfolio Planning. Proceedings Foundations of Computer-Aided Process

Operation. (FOCAPO2003). 241-244.

Rogers, M.J., Ding, M. and Maranas, C.D. (2004) Valuation and Design of Pharmaceutical R&D Licensing. AIChE Journal, 49(4): 851-855.

Sender, G.L. (1994) Option analysis at Merck. Harvard Business Review. Jan/Feb:92.

Shah, N. (2004) Pharmaceutical supply chains: key issues and strategies for optimization. Computer and Chemical Engineering. 28: 929-941.

Sharp, W.F. (1964) Capital Asset Prices: A Theory of Market Equilibrium under Condition of Risk. Journal of Finance. 19(3): 425-442.

Smit H.T., Trigeorgis, L. (2006) Strategic Planning: Valuing and Managing Portfolios of Real Options. R&D Management, 36: 403-419.

Smith, J.E. and Nay, R.F. (1995) Valuing Risky Projects: Option Pricing Theory and Decision Analysis. Management Science. 41(5): 795-816.

Subrahmanyam, S., Pekny, J. F. and Reklaitis, G. V. (1994) Design of batch chemical plants under market uncertainty. Industrial and Engineering Chemistry Research, 33, 2688-2701.

Subrahmanyam, S. (1996) Issues in the Design and Planning of Batch Chemical Plants. Ph.D thesis, Purdue University, West Lafayette, Indiana.

Towill, M.M. and Naim, J. Wikner. (2000) Industrial Dynamics Simulation Models in the Design of Supply Chains. International Journal of Physical Distribution & Logistics Management, 22(5): 2-13.

Trigeorgis, L. (1993) Real Options and Interactions with Financial Flexibility. Financial Management.

(3): 202.



  • There are currently no refbacks.




© Copyright 2011 Chinese Association of Overseas Postdocs and Scholars (CAOPS) | ISSN 1927-8780 (Print) 1927-8799 (Online) |


Hosted by Journal Publishing Services and School of Graduate Studies, University of Toronto; Supported by RiskLab,University of Toronto Facebook Follow us on Twitter

crossref RiskLab/CAOPS Publishing is a Member of CrossRef